The Traveller's Risk Perception (TRiP) questionnaire: pre-travel assessment and post-travel changes.
disease
perception
questionnaire
risk
travel
Journal
International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095
Informations de publication
Date de publication:
12 02 2020
12 02 2020
Historique:
received:
14
11
2018
revised:
18
03
2019
accepted:
14
06
2019
pubmed:
12
7
2019
medline:
29
4
2020
entrez:
12
7
2019
Statut:
ppublish
Résumé
Travellers' risk perception is a key component of travel risk assessment because it influences the adequate implementation of safety precautions. The aims of this study are to validate a tool to analyse travellers' risk perception to identify which factors can influence it and how it changes upon return. The Traveller's Risk Perception (TRiP) questionnaire was developed and administered to outpatients before and after travel in three travel clinics. A principal component analysis (PCA) was performed to validate the questionnaire and multivariate regression analysis was used to evaluate the effect of travellers' characteristics on the risk scores. A total of 1020 travellers completed the questionnaire. PCA identified two latent factors: 'generic-disseminated risks' and 'specific-circumstantial risks'. Cronbach's α was acceptable (0.76 and 0.70, respectively). The 'generic-disseminated risks' dimension scored higher than the 'specific-circumstantial risks' (p<0.001). The items with the highest scores were insect bites, gastrointestinal disorders and malaria. The mean scores were significantly lower after the travel for all items but one. The TRiP questionnaire is a valid and reliable tool for rating travellers' perceptions. Staff in travel clinics should be trained to systematically assess travellers' risk perception in order to tailor the consultation according to specific information needs.
Sections du résumé
BACKGROUND
Travellers' risk perception is a key component of travel risk assessment because it influences the adequate implementation of safety precautions. The aims of this study are to validate a tool to analyse travellers' risk perception to identify which factors can influence it and how it changes upon return.
METHODS
The Traveller's Risk Perception (TRiP) questionnaire was developed and administered to outpatients before and after travel in three travel clinics. A principal component analysis (PCA) was performed to validate the questionnaire and multivariate regression analysis was used to evaluate the effect of travellers' characteristics on the risk scores.
RESULTS
A total of 1020 travellers completed the questionnaire. PCA identified two latent factors: 'generic-disseminated risks' and 'specific-circumstantial risks'. Cronbach's α was acceptable (0.76 and 0.70, respectively). The 'generic-disseminated risks' dimension scored higher than the 'specific-circumstantial risks' (p<0.001). The items with the highest scores were insect bites, gastrointestinal disorders and malaria. The mean scores were significantly lower after the travel for all items but one.
CONCLUSIONS
The TRiP questionnaire is a valid and reliable tool for rating travellers' perceptions. Staff in travel clinics should be trained to systematically assess travellers' risk perception in order to tailor the consultation according to specific information needs.
Identifiants
pubmed: 31294781
pii: 5531301
doi: 10.1093/inthealth/ihz033
pmc: PMC7057134
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116-124Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Malar J. 2010 Oct 04;9:266
pubmed: 20920352
Lancet Infect Dis. 2013 Mar;13(3):205-13
pubmed: 23182931
Int Rev Psychiatry. 2007 Jun;19(3):279-88
pubmed: 17566905
Int Health. 2015 Nov;7(6):375-6
pubmed: 26078388
Malar J. 2008 Nov 10;7:235
pubmed: 19000299
Clin Infect Dis. 2010 Mar 15;50(6):826-32
pubmed: 20156059
J Travel Med. 2001 Mar-Apr;8(2):66-75
pubmed: 11285165
J Travel Med. 2013 Jan-Feb;20(1):3-10
pubmed: 23279224
Int Health. 2015 Jul;7(4):272-9
pubmed: 25376885
Infect Dis Clin North Am. 2012 Sep;26(3):575-93
pubmed: 22963771
J Health Econ. 2010 Jan;29(1):1-28
pubmed: 19963292
N Engl J Med. 2016 Jul 21;375(3):247-60
pubmed: 27468061
J Travel Med. 2015 Jan-Feb;22(1):1-12
pubmed: 25378212
Eur J Public Health. 2016 Oct;26(5):794-799
pubmed: 27085191
Risk Anal. 2015 Mar;35(3):536-52
pubmed: 25264264
Int Health. 2015 May;7(3):163-8
pubmed: 25808163
Travel Med Infect Dis. 2016 Jul-Aug;14(4):360-72
pubmed: 27238906
Mayo Clin Proc Innov Qual Outcomes. 2017 Apr 28;1(1):78-90
pubmed: 30225404
Neth J Med. 2015 Jun;73(5):219-26
pubmed: 26087801
J Travel Med. 2016 Oct 30;24(1):
pubmed: 27799502
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30107438
Int J Infect Dis. 2010 Oct;14(10):e842-51
pubmed: 20580587
BMJ. 2012 Nov 06;345:e7179
pubmed: 23131670